MetaADEDB 2.0 @ LMMD
Mefloquine
(WESWYMRNZNDGBX-YLCXCWDSSA-N)
Structure
SMILES
O[C@@H](c1cc(nc2c1cccc2C(F)(F)F)C(F)(F)F)[C@H]1CCCCN1.Cl
Molecular Formula:
C17H17ClF6N2O
Molecular Weight:
414.773
Log P:
5.5787
Hydrogen Bond Acceptor:
3
Hydrogen Bond Donor:
3
TPSA:
45.15
CAS Number(s):
51742-86-0; 51773-92-3
Synonym(s)
1.
Mefloquine
2.
Lariam
3.
Mefloquine Hydrochloride
4.
Mephloquine
5.
Ro-21-5998-001
6.
WR-142,490
7.
WR-177,602
8.
Ro 21 5998 001
9.
Ro215998001
10.
WR 142,490
11.
WR 177,602
12.
WR142,490
13.
WR177,602
External Link(s)
MeSHD015767
PubChem Compound65329
ChEBI6719
CHEMBLCHEMBL1606
KEGGdr:D00831
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1AnxietyFAERS: 32
Canada Vigilance: 7
Canada Vigilance
US FAERS
2DizzinessFAERS: 16
Canada Vigilance: 4
Canada Vigilance
US FAERS
3HeadacheFAERS: 16US FAERS
4ParanoiaFAERS: 15
Canada Vigilance: 1
Canada Vigilance
US FAERS
5NauseaFAERS: 12
Canada Vigilance: 2
Canada Vigilance
US FAERS
6AmnesiaFAERS: 10US FAERS
7TinnitusFAERS: 9US FAERS
8DeliriumFAERS: 8
Canada Vigilance: 2
Canada Vigilance
US FAERS
9Mood swingsFAERS: 8US FAERS
10PalpitationsFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
11Personality ChangeFAERS: 7US FAERS
12AgitationFAERS: 6
Canada Vigilance: 2
Canada Vigilance
US FAERS
13Emotional disorderFAERS: 6US FAERS
14FatigueFAERS: 6US FAERS
15Feeling abnormalFAERS: 6
Canada Vigilance: 2
Canada Vigilance
US FAERS
16Nephrotic SyndromeFAERS: 6US FAERS
17VertigoFAERS: 6US FAERS
18AngerFAERS: 5US FAERS
19Memory impairmentFAERS: 5US FAERS
20RestlessnessFAERS: 5US FAERS
21TremorFAERS: 5US FAERS
22Visual ImpairmentFAERS: 5
Canada Vigilance: 2
Canada Vigilance
US FAERS
23VomitingFAERS: 5US FAERS
24AstheniaFAERS: 4US FAERS
25Blood creatinine increasedFAERS: 4US FAERS
26CryingFAERS: 4US FAERS
27LethargyFAERS: 4US FAERS
28Toxicity to various agentsFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
29Weight decreasedFAERS: 4US FAERS
30AbasiaFAERS: 3US FAERS
31ArthralgiaFAERS: 3US FAERS
32Chest discomfortFAERS: 3US FAERS
33ChillsFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
34DeafnessFAERS: 3US FAERS
35DisorientationFAERS: 3US FAERS
36Flight of ideasFAERS: 3US FAERS
37Impaired work abilityFAERS: 3US FAERS
38MalaiseFAERS: 3US FAERS
39PainFAERS: 3US FAERS
40PoisoningFAERS: 3US FAERS
41Postural Orthostatic Tachycardia SyndromeFAERS: 3US FAERS
42ApathyFAERS: 2US FAERS
43AphasiaFAERS: 2US FAERS
44Depressed Level of ConsciousnessFAERS: 2US FAERS
45Depressed moodFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
46Drug ineffectiveFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
47Drug toxicityFAERS: 2US FAERS
48Emotional povertyFAERS: 2US FAERS
49Feeling jitteryFAERS: 2US FAERS
50FlushingFAERS: 2US FAERS
51Hallucinations, mixedFAERS: 2US FAERS
52HypersomniaFAERS: 2US FAERS
53HypomaniaFAERS: 2US FAERS
54LeukocytosisFAERS: 2US FAERS
55Medication ErrorFAERS: 2US FAERS
56Musculoskeletal PainFAERS: 2US FAERS
57PhotophobiaFAERS: 2US FAERS
58Plasmodium falciparum infectionFAERS: 2US FAERS
59PregnancyFAERS: 2US FAERS
60PruritusFAERS: 2US FAERS
61Sinus TachycardiaFAERS: 2US FAERS
62StillbirthFAERS: 2US FAERS
63Abdominal PainFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
64Activities of daily living impairedFAERS: 1US FAERS
65Acute psychosisFAERS: 1US FAERS
66AgeusiaFAERS: 1US FAERS
67Alanine aminotransferase decreasedFAERS: 1US FAERS
68AnorexiaFAERS: 1US FAERS
69BelligerenceFAERS: 1US FAERS
70Bipolar DisorderFAERS: 1US FAERS
71Blood albumin decreasedFAERS: 1US FAERS
72Blood potassium decreasedFAERS: 1US FAERS
73Blood sodium decreasedFAERS: 1US FAERS
74Blood urine presentFAERS: 1US FAERS
75Brain stem syndromeFAERS: 1US FAERS
76Burning sensationFAERS: 1US FAERS
77Chest PainFAERS: 1US FAERS
78Cold sweatFAERS: 1US FAERS
79Deep Vein ThrombosisFAERS: 1US FAERS
80Diffuse alveolar damageFAERS: 1US FAERS
81DissociationFAERS: 1US FAERS
82Dissociative disorderFAERS: 1US FAERS
83Ear discomfortFAERS: 1US FAERS
84Educational problemFAERS: 1US FAERS
85Emotional distressFAERS: 1US FAERS
86EncephaloceleFAERS: 1US FAERS
87Feeling of body temperature changeFAERS: 1US FAERS
88Fibrin D dimer increasedFAERS: 1US FAERS
89FlatulenceFAERS: 1US FAERS
90Global AmnesiaFAERS: 1US FAERS
91HepatitisFAERS: 1US FAERS
92HepatomegalyFAERS: 1US FAERS
93Histamine intoleranceFAERS: 1US FAERS
94HomicideFAERS: 1US FAERS
95HypervigilanceFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
96Impaired driving abilityFAERS: 1US FAERS
97ImpetigoFAERS: 1US FAERS
98Inappropriate schedule of drug administrationFAERS: 1US FAERS
99Inappropriate schedule of product administrationFAERS: 1US FAERS
100LentigoFAERS: 1US FAERS
101MalariaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
102Maternal exposure during pregnancyFAERS: 1US FAERS
103MetamorphopsiaFAERS: 1US FAERS
104Middle insomniaFAERS: 1US FAERS
105Migraine with AuraFAERS: 1US FAERS
106Multiple allergiesFAERS: 1US FAERS
107MyalgiaFAERS: 1US FAERS
108Myocardial InfarctionFAERS: 1US FAERS
109Neck PainFAERS: 1US FAERS
110NervousnessFAERS: 1US FAERS
111Neuropsychiatric syndromeFAERS: 1US FAERS
112Night sweatsFAERS: 1US FAERS
113No adverse eventFAERS: 1US FAERS
114Nonspecific reactionFAERS: 1US FAERS
115Obsessive thoughtsFAERS: 1US FAERS
116Optic NeuritisFAERS: 1US FAERS
117OverdoseFAERS: 1US FAERS
118Partner stressFAERS: 1US FAERS
119Poor quality sleepFAERS: 1US FAERS
120Post-Traumatic Stress DisorderFAERS: 1US FAERS
121Product label issueFAERS: 1US FAERS
122Protein urine presentFAERS: 1US FAERS
123Psychiatric symptomFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
124Pulmonary toxicityFAERS: 1US FAERS
125Respiratory arrestFAERS: 1US FAERS
126SinusitisFAERS: 1US FAERS
127SomnambulismFAERS: 1US FAERS
128StomatitisFAERS: 1US FAERS
129TachycardiaFAERS: 1US FAERS
130ThirstFAERS: 1US FAERS
131Unevaluable eventFAERS: 1US FAERS
132UrticariaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
133Violence-related symptomFAERS: 1US FAERS
134Wrong drug administeredFAERS: 1US FAERS
135nervous system disorderFAERS: 1US FAERS
136Illogical thinkingCanada Vigilance: 2Canada Vigilance
137Lichen PlanusCanada Vigilance: 1Canada Vigilance
138ScreamingCanada Vigilance: 1Canada Vigilance
139SomnolenceCanada Vigilance: 1Canada Vigilance
140Stevens-Johnson SyndromeCanada Vigilance: 1Canada Vigilance
141Suicide attemptCanada Vigilance: 2Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120235

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.